Benzene with Alkyl Chains Is a Universal Scaffold for Multivalent Virucidal Antivirals.
Journal
ACS central science
ISSN: 2374-7943
Titre abrégé: ACS Cent Sci
Pays: United States
ID NLM: 101660035
Informations de publication
Date de publication:
22 May 2024
22 May 2024
Historique:
received:
11
01
2024
revised:
05
03
2024
accepted:
15
03
2024
medline:
27
5
2024
pubmed:
27
5
2024
entrez:
27
5
2024
Statut:
epublish
Résumé
Most viruses start their invasion by binding to glycoproteins' moieties on the cell surface (heparan sulfate proteoglycans [HSPG] or sialic acid [SA]). Antivirals mimicking these moieties multivalently are known as broad-spectrum multivalent entry inhibitors (MEI). Due to their reversible mechanism, efficacy is lost when concentrations fall below an inhibitory threshold. To overcome this limitation, we modify MEIs with hydrophobic arms rendering the inhibitory mechanism irreversible, i.e., preventing the efficacy loss upon dilution. However, all our HSPG-mimicking MEIs only showed reversible inhibition against HSPG-binding SARS-CoV-2. Here, we present a systematic investigation of a series of small molecules, all containing a core and multiple hydrophobic arms terminated with HSPG-mimicking moieties. We identify the ones that have irreversible inhibition against all viruses including SARS-CoV-2 and discuss their design principles. We show efficacy
Identifiants
pubmed: 38799657
doi: 10.1021/acscentsci.4c00054
pmc: PMC11117723
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1012-1021Informations de copyright
© 2024 The Authors. Published by American Chemical Society.
Déclaration de conflit d'intérêts
The authors declare the following competing financial interest(s): Y.Z., F.S., and M.G. are inventors of the patent Virucidal Compounds, Compositions and Uses Thereof. F.S. and P.J.S. are co-founders of a start-up company, Asterivir, that is developing similar antiviral molecules.